Hst Global, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020
November 14, 2020 at 01:10 am IST
Share
HST Global, Inc. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced operating loss was USD 34,682 compared to USD 55,008 a year ago. Net loss was USD 34,934 compared to net income of USD 540,992 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to basic earnings per share from continuing operations of USD 0.01 a year ago. For the nine months, operating loss was USD 113,321 compared to USD 126,074 a year ago. Net loss was USD 113,795 compared to net income of USD 452,052 a year ago. Basic loss per share from continuing operations was USD 0.03 compared to basic earnings per share from continuing operations of USD 0.01 a year ago.
HST Global, Inc. is an integrated health and wellness biotechnology company. The Company is focused on developing and /or acquiring a network of wellness centers worldwide that is primarily focused on the homeopathic and alternative treatment of late-stage cancer. The Company intends to acquire innovative products for the treatment of life-threatening diseases. The Company primarily focuses on homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late-stage cancer and/or life-threatening diseases. The Company has not generated any revenue.
HST GLOBAL, INC. 
